More than two years after the infamous Wannacry ransomware crippled medical facilities and other organisations worldwide...
The Life Science division of Philip Morris International (PMI) has launched a computational challenge to identify and te...
GlaxoSmithKline has announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for use i...
GE Healthcare and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for em...
Bristol-Myers Squibb Company has announced that its Board of Directors has elected three new independent Directors:...
The European Society of Cardiology (ESC) has published new clinical practice guidelines on the management of diabetes an...
New real world evidence (RWE) from the RELOADED and CALLIPER observational studies demonstrate rivaroxaban’s super...
Global cybersecurity company Kaspersky reveals an alarming trend observed in the pharmaceutical industry – a year-...
Celgene Corporation’s INREBIC (fedratinib) became the first drug to be approved by the U S Food and Drug Administr...
Boehringer Ingelheim and Lupin Limited (Lupin) has announced a licensing, development and commercialization agreement fo...
Schrödinger, scientific leader in developing state-of-the-art chemical simulation software, has announced...
Cidara Therapeutics, Inc. and Mundipharma have announced that they have entered into a strategic partnership to develop ...
Velabs Therapeutics GmbH (Velabs), a biotech company focused on the rapid screening of functional therapeutic antibodies...
Abbott, a global health care company, launches in Brazil its ID NOW ™point of care molecular platfo...
The World Health Organization (WHO) recently posted a report showing the effectiveness of spatial repellents in fighting...
BioCity, the pioneering life science incubator and business collective, on 29 August 2019, announced an investment in pr...
Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (P...
Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company, and Pharmaceutical Product Development, LL...
